Patent · US Active

Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions

US9005961B2 · kind B2 · utility

5Cited by

11References

11Claims

0Family size

Assignees

INSTITUT PASTEUR · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Frédéric Tangy · Les Lilas, FR
Chantal Combredet · Paris, FR
Valerie Labrousse-Najburg · Crespières, FR
Michel Brahic · Poissy, FR

Key dates

Filing date	Dec 17, 2004
Grant date	Apr 14, 2015
Priority date	—
Expiry date	Dec 6, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a cDNA molecule which encodes the nucleotide sequence of the full length antigenomic (+)RNA strand of a measles virus (MV) originating from an approved vaccine strain, for example, the Schwarz strain. It also concerns the preparation of infectious recombinant viruses and immunogenic compositions using the cDNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.